Engineering Photothermal Catalytic CO 2 Nanoreactor for Osteomyelitis Treatment by In Situ CO Generation

• Published in: Advanced science 2024-07, Vol.11 (25), p.e2402256
• Main Authors: Zhuang, Fan, Jing, Luxia, Xiang, Huijing, Li, Cuixian, Lu, Beilei, Yan, Lixia, Wang, Jingjing, Chen, Yu, Huang, Beijian
• Format: Article
• Language: English
• Subjects: Animals; Anti-Bacterial Agents - pharmacology; Carbon Dioxide - metabolism; Carbon Monoxide; Catalysis; Disease Models, Animal; Mice; Osteomyelitis - therapy; Photothermal Therapy - methods
• ISSN: 2198-3844; 2198-3844
• DOI: 10.1002/advs.202402256

Photocatalytic carbon dioxide (CO ) reduction is an effective method for in vivo carbon monoxide (CO) generation for antibacterial use. However, the available strategies mainly focus on utilizing visible-light-responsive photocatalysts to achieve CO generation. The limited penetration capability of visible light hinders CO generation in deep-seated tissues. Herein, a photothermal CO catalyst (abbreviated as NNBCs) to achieve an efficient hyperthermic effect and in situ CO generation is rationally developed, to simultaneously suppress bacterial proliferation and relieve inflammatory responses. The NNBCs are modified with a special polyethylene glycol and further embellished by bicarbonate (BC) decoration via ferric ion-mediated coordination. Upon exposure to 1064 nm laser irradiation, the NNBCs facilitated efficient photothermal conversion and in situ CO generation through photothermal CO catalysis. Specifically, the photothermal effect accelerated the decomposition of BC to produce CO for photothermal catalytic CO production. Benefiting from the hyperthermic effect and in situ CO production, in vivo assessments using an osteomyelitis model confirmed that NNBCs can simultaneously inhibit bacterial proliferation and attenuate the photothermal effect-associated pro-inflammatory response. This study represents the first attempt to develop high-performance photothermal CO nanocatalysts to achieve in situ CO generation for the concurrent inhibition of bacterial growth and attenuation of inflammatory responses.